Michael D. Saxe
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signaling.
Journal: Frontiers in pharmacology
Published: May 09, 2025
RO4938581, a GABAA-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome.
Journal: Molecular psychiatry
Published: October 30, 2024
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Male Mice.
Journal: Biological psychiatry global open science
Published: May 16, 2024
Pharmacological Enhancement of Adult Hippocampal Neurogenesis Improves Behavioral Pattern Separation in Young and Aged Mice.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
Enhanced Social Dominance and Altered Neuronal Excitability in the Prefrontal Cortex of Male KCC2b Mutant Mice.
Journal: Autism research : official journal of the International Society for Autism Research
Published: January 05, 2019
Sleep/Wake Physiology and Quantitative Electroencephalogram Analysis of the Neuroligin-3 Knockout Rat Model of Autism Spectrum Disorder.
Journal: Sleep
Published: September 29, 2017
Cntnap2 Knockout Rats and Mice Exhibit Epileptiform Activity and Abnormal Sleep-Wake Physiology.
Journal: Sleep
Published: December 02, 2016
Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis.
Journal: Scientific reports
Published: October 11, 2016
Advancing the discovery of medications for autism spectrum disorder using new technologies to reveal social brain circuitry in rodents.
Journal: Psychopharmacology
Published: May 15, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026